Cushman M, Nagarathnam D, Gopal D, He H M, Lin C M, Hamel E
Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, Indiana 47907.
J Med Chem. 1992 Jun 12;35(12):2293-306. doi: 10.1021/jm00090a021.
A series of stilbenes has been prepared and tested for cytotoxicity in the five human cancer cell lines A-549 non-small cell lung, MCF-7 breast, HT-29 colon, SKMEL-5 melanoma, and MLM melanoma. The cis stilbenes 6a-f proved to be cytotoxic in all five cell lines, with potencies comparable to that of combretastatin A-4. These cytotoxic compounds were all potent inhibitors of tubulin polymerization. The corresponding trans stilbenes 7b-f were inactive as tubulin polymerization inhibitors and were significantly less cytotoxic in the five cancer cell lines. In the dihydro series, 8b, 8c, and 8f were inactive as tubulin polymerization inhibitors, while 8a, 8d, and 8e were less active than the corresponding cis compounds 6a, 6d, and 6e. The lack of tubulin polymerization inhibitory activity and cytotoxicity displayed by the phenanthrene 23b, which was synthesized as a conformationally rigid analogue of the lead compound 1, indicates that the activity of the stilbenes is not due to a totally planar conformation. Similarly, inactivity of the conformationally restricted analogue 26 suggests that the biologically active conformation of 1a resembles that of the cis alkene 1. Additional inactive compounds prepared include the benzylisoquinoline series 28-32 as well as the protoberberines 38 and 39. Shortening the two-carbon bridge of 1a to a one-carbon bridge in the diphenylmethane 20 resulted in a decrease in cytotoxicity and tubulin polymerization inhibitory activity. Although the corresponding benzophenone 18 was as active as 1a as a tubulin polymerization inhibitor, it was less cytotoxic than 1a, and the benzhydrol 19 was essentially inactive. With the exception of the amide 15c, which displayed low antitubulin activity, all of the phenylcinnamic acid derivatives 14a-c and 15a-f were inactive in the tubulin polymerization inhibition assay. The acid 14b and the ester 15a were cytotoxic in several of the cancer cell cultures in spite of their inactivity as tubulin polymerization inhibitors.
已制备了一系列芪类化合物,并在五种人类癌细胞系中测试了其细胞毒性,这五种细胞系分别是A-549非小细胞肺癌细胞系、MCF-7乳腺癌细胞系、HT-29结肠癌细胞系、SKMEL-5黑色素瘤细胞系和MLM黑色素瘤细胞系。顺式芪类化合物6a-f在所有五种细胞系中均表现出细胞毒性,其效力与康普瑞他汀A-4相当。这些具有细胞毒性的化合物都是微管蛋白聚合的有效抑制剂。相应的反式芪类化合物7b-f作为微管蛋白聚合抑制剂没有活性,并且在这五种癌细胞系中的细胞毒性明显较低。在二氢系列中,8b、8c和8f作为微管蛋白聚合抑制剂没有活性,而8a、8d和8e的活性低于相应的顺式化合物6a、6d和6e。作为先导化合物1的构象刚性类似物合成的菲23b缺乏微管蛋白聚合抑制活性和细胞毒性,这表明芪类化合物的活性并非源于完全平面的构象。同样,构象受限类似物26没有活性表明1a的生物活性构象与顺式烯烃1的构象相似。制备的其他无活性化合物包括苄基异喹啉系列28-32以及原小檗碱38和39。在二苯甲烷20中将1a的二碳桥缩短为一碳桥导致细胞毒性和微管蛋白聚合抑制活性降低。尽管相应的二苯甲酮18作为微管蛋白聚合抑制剂与1a活性相当,但其细胞毒性低于1a,而二苯甲醇19基本没有活性。除了表现出低抗微管蛋白活性的酰胺15c外,所有苯基肉桂酸衍生物14a-c和15a-f在微管蛋白聚合抑制试验中均无活性。尽管酸14b和酯15a作为微管蛋白聚合抑制剂没有活性,但它们在几种癌细胞培养物中具有细胞毒性。